{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:23:41Z","timestamp":1761895421109},"reference-count":34,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Economics"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.3111\/13696998.2011.653511","type":"journal-article","created":{"date-parts":[[2012,2,9]],"date-time":"2012-02-09T13:13:08Z","timestamp":1328793188000},"page":"454-464","source":"Crossref","is-referenced-by-count":3,"title":["Cost-effectiveness of zoledronic acid vs clodronic acid for newly-diagnosed multiple myeloma from the United Kingdom healthcare system perspective"],"prefix":"10.3111","volume":"15","author":[{"given":"Thomas E.","family":"Delea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Chandiwana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manjinder","family":"Bains","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"El Ouagari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satyin","family":"Kaura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gareth J.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2012,2,9]]},"reference":[{"key":"CIT0005","first-page":"CD003188.","author":"Mhaskar R","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/cncr.21104","volume":"104","author":"Corso A","year":"2005","journal-title":"Cancer"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2003.18.3.482"},{"key":"CIT0008","first-page":"377","volume":"7","author":"Rosen LS","year":"2001","journal-title":"Cancer J"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1158\/1535-7163.MCT-07-0311","volume":"6","author":"Scavelli C","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2713086.x"},{"key":"CIT0011","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2007.01.031","volume":"354","author":"Uchida R","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1007\/BF02698044"},{"issue":"15","key":"CIT0013","first-page":"8021","volume":"28","author":"Morgan G","year":"2010","journal-title":"ASCO Meeting Abstracts"},{"issue":"8","key":"CIT0014","first-page":"viii350","volume":"21","author":"Morgan G","year":"2010","journal-title":"Ann Oncol"},{"key":"CIT0015","first-page":"311","volume":"116","author":"Morgan GJ","year":"2010","journal-title":"ASH Annual Meeting Abstracts"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-06-357038"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(10)62051-X","volume":"376","author":"Morgan GJ","year":"2010","journal-title":"Lancet"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/88.15.1039"},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1600-0609.2010.01526.x","volume":"85","author":"Hornberger J","year":"2010","journal-title":"Eur J Haematol"},{"key":"CIT0020","volume-title":"The clinical and cost-effectiveness of bortezomib and thalidomide for the first-line treatment of multiple myeloma: a systematic review and economic evaluation","author":"Picot J","year":"2010"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1177\/0272989X9301300409","volume":"13","author":"Sonnenberg FA","year":"1993","journal-title":"Med Decis Making"},{"key":"CIT0022","volume-title":"Addendum to CADTH\u2019s guidelines for the economic evaluation of health technologies: specific guidance for oncology products","author":"Mittmann N","year":"2009"},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00019053-199711020-00005","volume":"11","author":"Siegel JE","year":"1997","journal-title":"Pharmacoeconomics"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1046\/j.1524-4733.2003.00234.x"},{"key":"CIT0025","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/S0197-2456(03)00072-2","volume":"24","author":"Carroll KJ","year":"2003","journal-title":"Control Clin Trials"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11701"},{"issue":"6","key":"CIT0028","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s10198-010-0272-0","volume":"12","author":"Botteman MF","year":"2011","journal-title":"Eur J Health Econ"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1007\/s005200100249"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/147323000803600304","volume":"36","author":"Paterson A","year":"2008","journal-title":"J Int Med Res"},{"key":"CIT0033","volume-title":"Unit costs of health and social care 2010","author":"Curtis L","year":"2010"},{"key":"CIT0035","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/00019053-200725050-00002","volume":"25","author":"Pickard AS","year":"2007","journal-title":"Pharmacoeconomics"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2005.08101.x"},{"key":"CIT0038","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/PPO.0b013e3181bef8cd","volume":"15","author":"Wilkerson J","year":"2009","journal-title":"Cancer J"},{"key":"CIT0039","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/1099-1050(200010)9:7<623::AID-HEC539>3.0.CO;2-V","volume":"9","author":"Lothgren M","year":"2000","journal-title":"Health Econ"},{"key":"CIT0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bmj.329.7459.224","volume":"329","author":"Rawlins MD","year":"2004","journal-title":"BMJ"},{"key":"CIT0041","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/hec.864","volume":"13","author":"Devlin N","year":"2004","journal-title":"Health Econ"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-5-70"},{"key":"CIT0043","first-page":"451","volume":"65","author":"Weissenfeld J","year":"2010","journal-title":"Pharmazie"}],"container-title":["Journal of Medical Economics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.3111\/13696998.2011.653511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T11:03:29Z","timestamp":1561287809000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.3111\/13696998.2011.653511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2012,1,13]]},"published-print":{"date-parts":[[2012,1]]}},"alternative-id":["10.3111\/13696998.2011.653511"],"URL":"https:\/\/doi.org\/10.3111\/13696998.2011.653511","relation":{},"ISSN":["1369-6998","1941-837X"],"issn-type":[{"value":"1369-6998","type":"print"},{"value":"1941-837X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}